New restrictions on prescribing hydroxychloroquine for COVID-19 The following is an extract from the TGA website of this alert: 24 March 2020 In recent days there has been considerable focus on the potential for hydroxychloroquine and the similar compound chloroquine (which is not marketed in Australia) to help in treating COVID-19. Hydroxychloroquine is used…
COVID-19 & Access to Hydroxychloroquine At present the trials are ongoing and there isn’t sufficient evidence to conclude whether it will be effective. Science Magazine stated that the available evidence that chloroquine and hydroxychloroquine work against COVID-19 was ‘thin’. The U.S. Society of Critical Care Medicine said “there is insufficient evidence to issue a recommendation…
International Lupus Community Reaches First-Ever Agreement on Barriers to Research, Drug Development, Care and Access Findings from a study published in Lupus Science & Medicine™ provide an actionable framework to advance the lupus field, which has seen many failed clinical trials, variations in care and poor access to care worldwide. The study, “Global Consensus Building…